Alberto Carmona‐Bayonas

Prospective validation of a prognostic score for patients in immunotherapy phase I trials: The Gustave Roussy Immune Score (GRIm-Score)

Frédéric Bigot, Eduardo Castañón, Capucine Baldini et al. · European Journal of Cancer · 2017 · 215 citations

Prognostic Evaluation, Autoimmune Disease, Immunotherapy Phase +10

Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Juan Virizuela Echaburu et al. · Journal of Clinical Oncology · 2015 · 156 citations · Full text

Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE)

Barbara Nuñez-Valdovinos, Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca et al. · The Oncologist · 2018 · 90 citations · Full text

Prognostic evaluation of febrile neutropenia in apparently stable adult cancer patients

Alberto Carmona‐Bayonas, J Gómez, Enrique González‐Billalabeitia et al. · British Journal of Cancer · 2011 · 79 citations · Full text

Prediction of Progression-Free Survival in Patients With Advanced, Well-Differentiated, Neuroendocrine Tumors Being Treated With a Somatostatin Analog: The GETNE-TRASGU Study

Alberto Carmona‐Bayonas, Paula Jiménez‐Fonseca, Ángela Lamarca et al. · Journal of Clinical Oncology · 2019 · 69 citations · Full text